Officials at J&J were surprised at the size of the sum that prosecutors are seeking, according to the people familiar with the matter. Prosecutors have been citing as a benchmark a $1.4 billion settlement that Eli Lilly & Co. reached in 2009 to resolve a probe into alleged improper marketing of its antipsychotic drug Zyprexa, according to one of the people. Lilly's alleged misconduct took place over a longer period of time, this person said.
From the Wall Street Journal, go here to read more.
More Insight and Advice for Caregivers
- Communicating in Alzheimer's World
- What’s the Difference Between Alzheimer’s Disease and Dementia
- How the Loss of Memory Works in Alzheimer’s Disease, and How Understanding This Could Help You
- Learning How to Communicate with Someone Suffering From Alzheimer's Disease
- What is Alzheimer's Disease?
- What is Dementia?
- Alzheimer's World -- Trying to Reconnect with Someone Suffering from Alzheimer's Disease
- Advice and Insight -- Alzheimer's Reading Room
- Dementia and the Eight Types of Dementia
- Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients
- Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes
- The Mini-Cog Test for Alzheimer's and Dementia
- Alzheimer's Disease, Urinary Tract Infections, Urinary Incontinence, Poop (8 Articles)
- 100 Good Reasons to Subscribe to the Alzheimer's Reading Room Now
Original content Bob DeMarco, the Alzheimer's Reading Room